Read the latest positive news, breakthroughs, and inspiring stories about lung cancer treatment, curated daily by BrightWire.
Small cell lung cancer patients are getting access to breakthrough treatments that target their specific tumors while causing almost no side effects. Clinical trials are making precision medicine available to more patients than ever before.
Scientists in Japan discovered that an immune protein older than blood itself could help cancer treatments work better when it's produced directly inside tumors. The breakthrough has already extended survival in mice with treatment-resistant cancer.
A newly approved lung cancer treatment offers hope for patients with a rare form of the disease, showing promising results with significantly fewer harsh side effects than existing options. The drug targets a specific genetic mutation affecting about 2% of lung cancer patients.
A breakthrough lung cancer treatment targeting a rare genetic mutation just won FDA approval two months ahead of schedule. The drug offers new hope for younger patients, often in their 40s and 50s, whose cancer stopped responding to earlier treatments.
UCLA researchers discovered a targeted therapy drug that dramatically reduces the risk of lung cancer returning in patients with a rare genetic subtype. After two years, 92% of patients receiving the treatment remained cancer-free, compared to just 61% who received a placebo.
A groundbreaking cancer treatment just showed remarkable results that exceeded doctors' expectations in treating one of the deadliest forms of lung cancer. The drug ivonescimab reduced the risk of death by 34% compared to standard treatment for patients with squamous non-small cell lung cancer.
A groundbreaking study from China reveals that lung cancer patients who receive immunochemotherapy before 3pm survive nearly twice as long. The discovery could transform treatment timing at no extra cost.
Scientists at Duke discovered an antibody that naturally helps some immune systems beat cancer—and turned it into an experimental drug. Early trials show promise in stopping lung tumors from growing.